Letter from the Editor
/
In my editorial for the last issue of this magazine, published shortly after the atrocities of October 7, I expressed my support for the Israeli survivors…
Read More
Latest News
Letter from the Editor
/
I was in the process of completing this issue of Migraineur when I first learned of the horrific events that were occurring in southern Israel…
Read MoreLetter from the Editor
/
In 2016, when we first conceived of publishing an “educational, but entertaining” magazine for the 12%…
Read MoreLetter from the Editor
/
After 6 years this magazine’s most frequently downloaded article remains “Migraine 101” from the Fall 2017 issue…
Read MoreLetter from the Editor
/
Just slightly less than 30 years ago, in December 1992, injectable sumatriptan (Imitrex) was approved by the FDA for the treatment of acute migraine headache…
Read MoreLetter from the Editor
/
After a gorgeous spring, western Maryland gave way to an equally gorgeous summer…
Read MoreLetter from the Editor
/
If you’re like me, Spring 2022 may be a time marked by cautious optimism uneasily blended with a grim sense of foreboding…
Read MoreLetter from the Editor
/
In a perfect world every new treatment for migraine would become available immediately to patients…
Read MoreLetter from the Editor
/
In 1992 the clinical emergence of injectable sumatriptan, the first “designer drug“ developed specifically for migraine, inaugurated a revolution…
Read MoreLetter from the Editor
/
For the healthcare provider who maintains a subspecialty interest in headache, a week can resemble one cycle of the ocean’s tide.
Read MoreLetter from the Editor
/
In 1984 I performed a lumbar puncture on a young man who had presented to our hospital in San Diego with a confusing constellation of issues…
Read MoreLetter from the Editor
/
With the exception of the tragedy of 9/11, there has been nothing in my lifetime to approximate how much, how rapidly and how pervasively the viral pandemic has changed our behavior and perspective…
Read MoreLetter from the Editor
/
While management of headache always has suffered from a “supply/demand” problem, the ongoing pandemic has served to highlight and aggravate that imbalance. Given the prevalence of headache in our society—and the prevalence of migraine in particular—there are simply too many citizens in need of headache management but too few providers available to meet that need. Again, COVID-19 has served to highlight this mismatch.
Read MoreLetter from the Editor
/
Within the period of only a few months, we have been challenged by profoundly stressful events that have influenced virtually every aspect of our day-to-day lives. The COVID-19 pandemic and the recent civil unrest have produced a pervasive sense of unease. The stress accompanying that unease impairs our ability to cope gracefully and healthfully with whatever obstacles we must face.
Read MoreLetter from the Editor
/
This is the first issue of Migraineur published since last spring, a pause made necessary by the unprecedented emergence of so many new therapies for headache occurring over such a short period of time.
Read MoreLetter from the Editor
/
Migraineur magazine a unique resource for those who seek “to live well despite migraine”. Written by medical professionals with extensive backgrounds in clinical work, research and education involving migraine, our informational content goes well beyond what typically is offered via headache websites and other health magazines.
Read MoreLetter from the Editor
/
Welcome to the inaugural issue of a magazine that is intended to both educate and entertain the many millions of Americans who suffer from migraine.
Read More
